Archive · 18 Nov 2025
Qure.ai Targets Govt Partnerships for TB Screening in India
Qure.ai, a company that uses AI to help diagnose diseases, is working with the Indian government to screen for tuberculosis (TB).
India has a lot of TB cases, so this is a big opportunity for Qure.ai.
They are already working with some state governments and hope to add many more hospitals in India this year.
They might use a special partnership model to do this.
Right now, most of Qure.ai's money comes from other countries, but they hope to make more money in India soon.
Qure.ai, an AI healthcare startup, is focusing on partnerships with Indian governments for TB screening
India accounts for 25% of global TB cases, making it a key market for Qure.ai
The company is collaborating with ICMR and state governments for TB screening programs
Qure.ai aims to add up to 3,000 hospitals worldwide this year, with a significant portion potentially from India
The company is considering the Public-Private Partnership model for integration of its technology
- Who
- Qure.ai, an AI healthcare startup
- What
- is focusing on partnerships with Indian governments for TB screening
- When
- Currently, with plans to expand in the next one or two years
- Where
- India, particularly in public health systems
- Why
- To tackle India's high TB burden and expand its reach within the country
Qure.ai's Stance
Market Reality
Market Opportunity
Qure.ai's Stance
Sees substantial opportunity in Indian government market for TB screening
Market Reality
India's private healthcare market uptake of AI remains slow
- Founded
- 2016
- Headquarters
- Mumbai, India
- CEO
- Prashant Warier
- Global Hospital Partnerships
- 4,500
- Indian Hospital Partnerships
- About 5-10% of global total